EdgarLookup

Ategrity Specialty Insurance Co Holdings — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Ategrity Specialty Insurance Co Holdings filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
17.4%
Profit Margin
Net income ÷ revenue
5%
Return on Assets
Net income ÷ assets
1.4x
Debt-to-Equity
Total liabilities ÷ equity
+23.4%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $424.34M Mar 6, 2026
FY2025 Dec 31, 2024 $343.83M Mar 6, 2026

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $74.00M Mar 6, 2026
FY2025 Dec 31, 2024 $47.09M Mar 6, 2026

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $147.19M Mar 6, 2026
FY2025 Dec 31, 2024 $125.61M Mar 6, 2026

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $6.47M Mar 6, 2026
FY2025 Dec 31, 2024 $164.0K Mar 6, 2026

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.47B Mar 6, 2026
FY2025 Dec 31, 2024 $1.12B Mar 6, 2026

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $859.45M Mar 6, 2026
FY2025 Dec 31, 2024 $724.63M Mar 6, 2026

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $614.31M Mar 6, 2026
FY2025 Dec 31, 2024 $398.31M Mar 6, 2026

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $108.57M Mar 6, 2026
FY2025 Dec 31, 2024 $34.57M Mar 6, 2026

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $29.72M Mar 6, 2026
FY2025 Dec 31, 2024 $26.57M Mar 6, 2026

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 1 Mar 6, 2026
FY2025 Dec 31, 2024 1 Mar 6, 2026

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 1 Mar 6, 2026
FY2025 Dec 31, 2024 1 Mar 6, 2026

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 48.07M Mar 6, 2026
FY2025 Dec 31, 2024 38.39M Mar 6, 2026